Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06518798 · ClinicalTrials.gov registry record · NA

Feasibility and Preliminary Effects of Fasting-Mimicking Diet in Asian Americans With Prediabetes

A NA study of PreDiabetes and Prediabetic State, sponsored by University of California, Irvine.

Completed
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT06518798: Completed NA study of PreDiabetes and Prediabetic State, sponsored by University of California, Irvine.

NCT06518798 is a NA study of PreDiabetes and Prediabetic State that has completed, run by University of California, Irvine. The registered enrollment target is 30 participants, below the 701-participant average among 149 other PreDiabetes trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06518798, a NA study of PreDiabetes and Prediabetic State, has completed, sponsored by University of California, Irvine.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

This is a pilot study to determine the feasibility of studying the Fasting-Mimicking Diet (FMD), a dietary approach that involves the consumption of a specifically formulated, calorie-restricted nutrition regimen with a customized macronutrient composition, ratio, and quantity over a 5- day period, on a larger scale in Asian Americans with prediabetes and to examine the preliminary effects of the diet in study participants. The main questions the study aims to answer are: 1. What are the recruitment, adherence, and attrition rates of eligible participants into the study? 2. Does one FMD cycle result in changes in fasting blood glucose levels and physical measurements in study participants? Participants will be asked to undergo one cycle of FMD (for 5 days), fill out surveys, and come in for a pre-FMD and post-FMD study visit, during which physical measurements and fasting blood glucose and ketone levels will be measured.

Primary Outcome

Recruitment rate will be determined based on the number of individuals who consented to be in the pilot Fasting Mimicking Diet trial per month.

Interventions

  • BEHAVIORAL Fasting Mimicking Diet

Study Locations (1)

California

  • UC Irvine - Irvine

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2024-08-12
Est. Completion 2025-05-09
Phase NA
University of California, Irvine

368 total trials

What the finished NCT06518798 record still lists

NCT06518798 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 701-participant average among 149 other PreDiabetes trials with a reported enrollment target (96% lower).

The record links to 2 conditions, with PreDiabetes appearing as the primary indexed condition, and to 1 intervention - of which Fasting Mimicking Diet is the first listed.

NCT06518798 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06518798 about?

NCT06518798 is a clinical study titled "Feasibility and Preliminary Effects of Fasting-Mimicking Diet in Asian Americans With Prediabetes". This is a pilot study to determine the feasibility of studying the Fasting-Mimicking Diet (FMD), a dietary approach that involves the consumption of a specifically formulated, calorie-restricted nutrition regimen with a customized macronutrient composition, ratio, and quantity over a 5- day period, ...

What is the current status of trial NCT06518798?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2024-08-12. Estimated completion is 2025-05-09.

What conditions does trial NCT06518798 study?

This clinical trial studies the following conditions: PreDiabetes, Prediabetic State.

What interventions are being tested in trial NCT06518798?

The interventions under investigation include: Fasting Mimicking Diet (BEHAVIORAL).

Who is sponsoring clinical trial NCT06518798?

This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06518798 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for PreDiabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06518798's enrollment target sits among peer trials

30 118th of 149 higher than 23 of 149 other PreDiabetes trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other PreDiabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06518798, the US trial registry maintained by the National Library of Medicine. NCT06518798 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.